The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer

Minoru Takada; Masahiro Fukuoka; Yutaka Ariyoshi; Kiyoyuki Furuse; Hisanobu Niitani; Kazuo Ota; Masakichi Motomiya; Kouichi Hasegawa; Keigo Tominaga; Takayuki Kuriyama; Kiyokazu Yoshida; Hitoshi Kimura; Yuzo Kurita; Shigenori Nakajima; Jun Nakai; Mituo Ohta; Hidehiko Yamamoto

doi:10.1007/bf00685545

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00685545 ◽

1992 ◽

Vol 31 (3) ◽

pp. 182-186 ◽

Cited By ~ 6

Author(s):

Minoru Takada ◽

Masahiro Fukuoka ◽

Yutaka Ariyoshi ◽

Kiyoyuki Furuse ◽

Hisanobu Niitani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(93)90261-u ◽

1993 ◽

Vol 10 (3-4) ◽

pp. 278

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text

Pegylated recombinant human granulocyte colony‐stimulating factor regulates the immune status of patients with small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.13322 ◽

2020 ◽

Vol 11 (3) ◽

pp. 713-722

Author(s):

Jing Sun ◽

Hua Bai ◽

Zhijie Wang ◽

Jianchun Duan ◽

Jin Li ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Status ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text

Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer

Anti-Cancer Drugs ◽

10.1097/00001813-200206000-00009 ◽

2002 ◽

Vol 13 (5) ◽

pp. 505-509 ◽

Cited By ~ 6

Author(s):

Akihisa Fujita ◽

Toshihiko Ohkubo ◽

Hideaki Hoshino ◽

Hirotsugu Takabatake ◽

Shigeru Tagaki ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Study ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text

Dose intensive weekly code chemotherapy (CT) with or without recombinant human granulocyte colony-stimulating factor (rhG-CSF) in extensive-stage (ES) small cell lung cancer (SCLC)

Lung Cancer ◽

10.1016/0169-5002(91)91811-o ◽

1991 ◽

Vol 7 ◽

pp. 123 ◽

Cited By ~ 2

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Extensive Stage ◽

Stimulating Factor

Download Full-text

Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(05)80345-4 ◽

1993 ◽

Vol 29 (5) ◽

pp. 677-680 ◽

Cited By ~ 12

Author(s):

Kiyoshi Mori ◽

Yoshikuni Saitoh ◽

Keigo Tominaga

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Intensive Chemotherapy ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text

Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC)

Clinical Oncology ◽

10.1016/s0936-6555(05)80536-9 ◽

1995 ◽

Vol 7 (5) ◽

pp. 293-299 ◽

Cited By ~ 8

Author(s):

N THATCHER ◽

P CLARK ◽

D SMITH ◽

H ANDERSON ◽

D GIRLING ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Intensity ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor ◽

Factor G

Download Full-text

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

European Journal of Cancer ◽

10.1016/0959-8049(96)00071-8 ◽

1996 ◽

Vol 32 (7) ◽

pp. 1263 ◽

Cited By ~ 3

Author(s):

D.J. Girling ◽

N. Thatcher ◽

P.I. Clark ◽

R.J. Stephens

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Intensity ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor ◽

Factor G

Download Full-text

Ifosfamide (I) in combination with navelbine (N) or taxol (T) and granulocyte colony stimulating factor (G-CSF) support in advanced non-small cell lung cancer (NSCLC): 2 parallel phase I-II trials

Lung Cancer ◽

10.1016/0169-5002(94)94240-4 ◽

1994 ◽

Vol 11 ◽

pp. 122

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor ◽

Factor G

Download Full-text

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)89030-2 ◽

1997 ◽

Vol 33 (3) ◽

pp. 503-505 ◽

Cited By ~ 7

Author(s):

K. Mori ◽

T. Hirose ◽

S. Machida ◽

K. Yokoyama ◽

K. Tominaga

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Study ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer

Oncotarget ◽

10.18632/oncotarget.25578 ◽

2018 ◽

Vol 9 (45) ◽

pp. 27789-27796 ◽

Cited By ~ 4

Author(s):

Akito Hata ◽

Daijiro Harada ◽

Chiyuki Okuda ◽

Reiko Kaji ◽

Yoshio Masuda ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Small Cell Lung ◽

Stimulating Factor

Download Full-text